n-methylnicotinamide has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffiths, HR; Lunec, J; Willets, JM; Williams, AC | 1 |
| Buttrum, S; Green, S; Molloy, H; Pall, HS; Steventon, GB; Waring, RH; Williams, AC | 1 |
2 other study(ies) available for n-methylnicotinamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; Humans; Isomerism; Kinetics; L-Lactate Dehydrogenase; Neuroblastoma; Neurotoxins; Niacinamide; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rotenone; Tumor Cells, Cultured | 1993 |
N-methylation of pyridines and Parkinson's disease.
Topics: Humans; Methylation; Methyltransferases; Niacinamide; Parkinson Disease; Pyridines; Pyridones | 1993 |